Medicines Co (MDCO.OQ)
17 Aug 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|69||2017||Executive Chairman of the Board|
|60||2015||Chief Executive Officer, Director|
|42||2018||Chief Financial Officer, Treasurer|
|53||2016||Executive Vice President, Chief Corporate Development Officer|
|42||2014||General Counsel, Secretary|
- REFILE-UPDATE 2-FDA knocks back Achaogen's drug for bloodstream infection
- BRIEF-Medicines Co Says CEO Clive A. Meanwell's 2017 Total Compensation Was $7.6 Million
- BRIEF-The Medicines Co Reports Q1 GAAP Loss Per Share $1.14 From Continuing Operations
- BRIEF-The Medicines Company Announces Chief Financial Officer Transition
- BRIEF-Medicines Co Says Board Appointed Christopher Visioli As CFO